A carregar...

Re-orienting the immune system: Durable tumor regression and successful re-induction therapy using anti-PD1 antibodies

The blockade of immune regulatory checkpoints is emerging as a powerful anticancer strategy. We recently reported long-term results from the first-in-human clinical trial of anti-PD1 antibody-based immunotherapy, demonstrating durable tumor control off-therapy in subjects affected by colorectal and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Lipson, Evan J.
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3654592/
https://ncbi.nlm.nih.gov/pubmed/23734322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.23661
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!